Strategic sequencing of bladder-sparing therapies in the management of BCG-unresponsive non-muscle invasive bladder cancer. Abou Chakra M, Boormans JL, Hayne D, O'Donnell MA, et al. Ann Med 2026;58:2612387.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Abou Chakra M, Boormans JL, Hayne D, O'Donnell MA, et al. Strategic sequencing of bladder-sparing therapies in the management of BCG-unresponsive non-muscle invasive bladder cancer. Ann Med 2026;58:2612387.
PMID: 41508603